Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult ...
Scientists engineered phages to act as scaffolds to carry silver nanoparticles. Together, the two bacteria-killing components ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its ...
Learn why child mortality is rising for the first time in our lives - and how smarter investments, innovation, and science ...
Pneumonia cases surge in winter as cold, pollution, and viruses weaken immunity. Dr. Agrawal urges early diagnosis, awareness ...
MedPage Today on MSN
How Has the Epidemiology of Meningitis Changed With Vaccine Advances?
The array of vaccines that have become widely available to help protect kids against meningitis in recent decades has shifted ...
Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...
WHO approves OS Therapies’ daznelimgene lisbac for non-proprietary name for product candidate OST-HER2: New York Thursday, November 27, 2025, 18:00 Hrs [IST] OS Therapies Inc, t ...
AMR MPTF saving lives and reducing economic loss in Zimbabwe ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
November 25, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced that the International ...
Joshua Lederberg, Nobel laureate and president of Rockefeller University, is well known in biology circles. Not so his wife, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback